CTL immuno therapies Pages on BioPortfolio:

BioPortfolio - CTL ImmunoTherapies - Profile
View the current CTL ImmunoTherapies Page on BioPortfolio.com ... CTL ImmunoTherapies, located in Chatsworth, California, is a biotechnology company
...
http://www.bioportfolio.com/biocorporate/3114-CTL+ImmunoTher...

Cancer Cell Therapy Markets
(Micromet, Inc.) 194; 4.6.7 Corixa (Acquired by GlaxoSmithKline) 194; 4.6.8 CTL Immunotherapies 194; 4.6.9 Dendreon 194; 4.6.10 GenEra 194 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1026.html...

BioPortfolio - Biocorporate Search biotechnology
CTL ImmunoTherapies, located in Chatsworth, California, is a biotechnology company focusing on the discovery, development and manufacturing of theraputic
...
http://www.bioportfolio.com/biocorporate/search.php?page=14&...

BioPortfolio - Immune Tolerance
Over the past decade, immune therapy has become a standard treatment for a. ... Cellular Technology Ltd. (CTL) Laboratories specializes in GLP compliant ...
http://www.bioportfolio.com/indepth/Immune_Tolerance.html...

BioPortfolio - Cross-Priming - InDepth
Critical issues for cytotoxic lymphocyte (CTL) cross-priming are (a) the...14th October, ... 6641812- Heat shock protein-based vaccines and immunotherapies ...
http://www.bioportfolio.com/indepth/Cross-Priming.pdf...

BioPortfolio - MannKind - Profile
6 Nov 2008 ... Tumor-associated antigens and biomarkers in cancer and immune therapy. Cancer has currently overtaken heart disease as the major cause ...
http://www.bioportfolio.com/biocorporate/25981-MannKind.pdf...

Cell Medica announces treatment of first patient in late stage ...
Two methods of adoptive cell therapy using CMV-specific memory T cells will be compared to a control arm receiving only conventional antiviral treatment. ...
http://www.bioportfolio.com/biotech_news/Cell_Medica_2.htm...

Soluble LAG-3 molecule amplifies tumor-specific immunity
Immutep S.A. is a biopharmaceutical company developing technologies for novel immunotherapies for the treatment of cancer and chronic infectious diseases ...
http://www.bioportfolio.com/biotech_news/Immutep_3.htm...

BioPortfolio - Austin Research Institute - Profile
immune responses. Cytoplasmic delivery of proteins or CTL epitopes is crucial for ... ALS Therapy Development Institute Receives $1 Million for Research ...
http://www.bioportfolio.com/biocorporate/1098-Austin+Researc...

Results from other life science and pharmaceutical sites:

RCC therapeutic vaccine strategies, or immunoatherapy
Active Immune Therapies | Passive Immune Therapies | Immunotherapies for RCC ... have not been very successful in activating a specific CTL response. ...
http://www.brown.edu/Courses/Bio_160/Projects2000/RCC/RCCthe...

[Adoptive immune therapy using EBV-specific CTL]
The Epstein-Barr virus (EBV) has been implicated in the etiology of many lymphoid and other malignan...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...

MUC1-specific immune therapy generates a strong anti-tumor ...
Recently it has become clear that activation of the CTL immune effector arm ...... from the MUC1 tumor antigen for broadly applicable vaccine therapies. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...

Analytical study of the clinical response to two distinct adoptive ...
To evaluate the effect of two distinct adoptive immunotherapies, tumor-specific cytotoxic T-cell (CTL) therapy and lymphokine-activated killer (LAK) cell ...
http://www.ncbi.nlm.nih.gov/pubmed/8811496...

EBV specific CTL: a model for immune therapy. [Vox Sang. 1998 ...
EBV specific CTL: a model for immune therapy. Rooney CM, Heslop HE, Brenner MK. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, ...
http://www.ncbi.nlm.nih.gov/pubmed/9704488...

Interruption of antiretroviral therapy to augment immune control ...
Interruption of antiretroviral therapy to augment immune control of chronic HIV- 1 infection: Risk without reward. Ume L. Abbas and John W. Mellors* ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=12...

[Adoptive immune therapy using EBV-specific CTL]
[Adoptive immune therapy using EBV-specific CTL]. [Article in Japanese]. Kuzushima K, Morishima T. Department of Pediatrics, Nagoya Ekisaikai Hospital.
...
http://www.ncbi.nlm.nih.gov/pubmed/9046843...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.